The oncology analytics software developer received a top-up from investors including NEC Corporation at a unicorn valuation.
US-based medical analytics software provider BostonGene has received $150m in series B funding from investors including IT services provider NEC Corporation at a valuation of over $1bn.
Impact Investment Capital and Japan Industrial Partners filled out the participants in the round, which followed $50m in series A funding from NEC in 2019.
BostonGene has created software that sequences a cancer patient’s individual genome to create an artificial intelligence (AI)-based molecular and immune profile to assess the state of their…
Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
